These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 25265316)

  • 1. Inhaler devices for chronic obstructive pulmonary disease: insights from patients and healthcare practitioners.
    Molimard M; Colthorpe P
    J Aerosol Med Pulm Drug Deliv; 2015 Jun; 28(3):219-28. PubMed ID: 25265316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maintenance inhaler preference, attribute importance, and satisfaction in prescribing physicians and patients with asthma, COPD, or asthma-COPD overlap syndrome consulting for routine care.
    Ding B; Small M; Scheffel G; Holmgren U
    Int J Chron Obstruct Pulmon Dis; 2018; 13():927-936. PubMed ID: 29588581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with appropriate inhaler use in patients with COPD - lessons from the REAL survey.
    Price D; Keininger DL; Viswanad B; Gasser M; Walda S; Gutzwiller FS
    Int J Chron Obstruct Pulmon Dis; 2018; 13():695-702. PubMed ID: 29520137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COPD: misuse of inhaler devices in clinical practice.
    Duarte-de-Araújo A; Teixeira P; Hespanhol V; Correia-de-Sousa J
    Int J Chron Obstruct Pulmon Dis; 2019; 14():1209-1217. PubMed ID: 31213798
    [No Abstract]   [Full Text] [Related]  

  • 5. An Exploratory Study of Physician Decision-Making When Treating Uncontrolled COPD.
    Kahle-Wrobleski K; Bui BKH; Friderici J; Moore KJ; Carlyle M; Webb NS; Martin CK; Pace WD; Westfall JM
    Int J Chron Obstruct Pulmon Dis; 2024; 19():1357-1373. PubMed ID: 38912054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of indacaterol on quality of life and pulmonary function in patients with COPD and inhaler device preferences.
    Ohno T; Wada S; Hanada S; Sawaguchi H; Muraki M; Tohda Y
    Int J Chron Obstruct Pulmon Dis; 2014; 9():107-14. PubMed ID: 24489464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Questionnaire on switching from the tiotropium HandiHaler to the Respimat inhaler in patients with chronic obstructive pulmonary disease: changes in handling and preferences immediately and several years after the switch.
    Hanada S; Wada S; Ohno T; Sawaguchi H; Muraki M; Tohda Y
    Int J Chron Obstruct Pulmon Dis; 2015; 10():69-77. PubMed ID: 25609941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Breathing New Life Into Chronic Obstructive Pulmonary Disease (COPD)" - Results From An Online Survey Of UK Patients.
    Titmarsh S; Poliziani M; Russell RE
    Int J Chron Obstruct Pulmon Dis; 2019; 14():2799-2807. PubMed ID: 31824144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient preferences for dry powder inhaler attributes in asthma and chronic obstructive pulmonary disease in France: a discrete choice experiment.
    Hawken N; Torvinen S; Neine ME; Amri I; Toumi M; Aballéa S; Plich A; Roche N
    BMC Pulm Med; 2017 Jul; 17(1):99. PubMed ID: 28683805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correct usage, ease of use, and preference of two dry powder inhalers in patients with COPD: analysis of five phase III, randomized trials.
    Riley JH; Tabberer M; Richard N; Donald A; Church A; Harris SS
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1873-80. PubMed ID: 27578968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. When to use single-inhaler triple therapy in COPD: a practical approach for primary care health care professionals.
    Gaduzo S; McGovern V; Roberts J; Scullion JE; Singh D
    Int J Chron Obstruct Pulmon Dis; 2019; 14():391-401. PubMed ID: 30863039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhaler devices in asthma and COPD patients - a prospective cross-sectional study on inhaler preferences and error rates.
    Schreiber J; Sonnenburg T; Luecke E
    BMC Pulm Med; 2020 Aug; 20(1):222. PubMed ID: 32819337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chinese expert consensus on standardized inhaler device application in stable chronic airway diseases (2023)].
    Inhalation Therapy and Respiratory Rehabilitation Group, Respiratory Equipment Committee of China Association of Medical Equipment
    Zhonghua Jie He He Hu Xi Za Zhi; 2023 Nov; 46(11):1055-1067. PubMed ID: 37914418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantifying the importance of inhaler attributes corresponding to items in the patient satisfaction and preference questionnaire in patients using Combivent Respimat.
    Davis KH; Su J; González JM; Trudeau JJ; Nelson LM; Hauber B; Hollis KA
    Health Qual Life Outcomes; 2017 Oct; 15(1):201. PubMed ID: 29037248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient preference for chronic obstructive pulmonary disease (COPD) treatment inhalers: a discrete choice experiment in France.
    Chouaid C; Germain N; De Pouvourville G; Aballéa S; Korchagina D; Baldwin M; Le Lay K; Luciani L; Toumi M; Devillier P
    Curr Med Res Opin; 2019 May; 35(5):785-792. PubMed ID: 30681007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of satisfaction with different dry powder inhalation devices in Greek patients with COPD and asthma: the ANASA study.
    Zervas E; Samitas K; Gaga M
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1845-55. PubMed ID: 27540287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Misuse of inhalers among COPD patients in a community hospital in Taiwan.
    Liang CY; Chen YJ; Sheu SM; Tsai CF; Chen W
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1309-1316. PubMed ID: 29719386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of multiple respiratory inhalers requiring different inhalation techniques has an adverse effect on COPD outcomes.
    Bosnic-Anticevich S; Chrystyn H; Costello RW; Dolovich MB; Fletcher MJ; Lavorini F; Rodríguez-Roisin R; Ryan D; Wan Yau Ming S; Price DB
    Int J Chron Obstruct Pulmon Dis; 2017; 12():59-71. PubMed ID: 28053517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Satisfaction with the Use of eFlow Closed-System Nebulizer in Patients with Moderate-to-Very Severe Chronic Obstructive Pulmonary Disease: Findings from a Long-Term Safety Study.
    Kerwin EM; Donohue JF; Ferguson GT; Ganapathy V; Ozol-Godfrey A; Rajagopalan K
    J Aerosol Med Pulm Drug Deliv; 2019 Feb; 32(1):24-33. PubMed ID: 30457433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tiotropium administered by a pressurized metered dose inhaler (pMDI) and spacer produces a similar bronchodilator response as that administered by a Rotahaler in adult subjects with stable moderate-to-severe COPD.
    Brashier B; Dhembare P; Jantikar A; Mahadik P; Gokhale P; Gogtay JA; Salvi SS
    Respir Med; 2007 Dec; 101(12):2464-71. PubMed ID: 17719763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.